Narjess Bostanghadiri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Narjess Bostanghadiri has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Roghayeh Mohammadzadeh
Food Safety Research Center (Salt) Semnan University of Medical Sciences Semnan Iran
4 shared publications- Erta Rajabi
Faculty of Medicine Tehran University of Medical Sciences Tehran Iran
3 shared publications Delaram Nourollahi
Research Center for Clinical Virology Tehran University of Medical Sciences Tehran Iran
2 shared publicationsMahsa Ghamari
Department of Pathobiology, School of Public Health Tehran University of Medical Sciences Tehran Iran
2 shared publicationsNegar Narimisa
2 shared publications- Shabnam Razavi
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 13 October 2026
- Published by Wiley in Microbiologyopen
- Vol. 15 (5) , e70434
Global Prevalence of Vancomycin‐Resistant Enterococcus faecium and Enterococcus faecalis Isolated From Clinical and Environmental Sources: A Systematic Review and Meta‐Analysis
Vancomycin‐resistant enterococci (VRE) are an increasing public health concern. However, the contribution of environmental reservoirs to the global epidemiology of vancomycin resistance remains unclear. This meta‐analysis estimated the prevalence of Vancomycin‐resistant Enterococcus faecalis (VREfs) and vancomycin‐resistant Enterococcus faecium (VREfm) from clinical and environmental specimens worldwide. We conducted a systematic literature search in PubMed, Web of Science, Embase, and Scopus up to 26 April 2025. Statistical analysis was performed using the meta and metaphor packages in R, and heterogeneity was evaluated using I 2 . We assessed potential publication bias using Egger's test. A total of 349 eligible studies were included. The pooled prevalence of VREfm was 25%, and VREfs was 5%. The prevalence of both VREfs and VREfm increased significantly during the last two decades. The highest prevalence of VREfm and VREfs was found in rectal swabs (76%), hospital environmental samples (74%), environmental water (26%), and animal stool (40%). By integrating clinical and environmental data, the present study highlights the possible role of non‐clinical reservoirs in the persistence and dissemination of VRE. Our results support the One Health approach for VRE surveillance and emphasize the need for environmental surveillance in infection prevention and antimicrobial resistance control strategies.
- 13 October 2026
- Published by Wiley in Microbiologyopen
- Vol. 15 (5) , e70434
Open AccessGlobal Prevalence of Vancomycin‐Resistant Enterococcus faecium and Enterococcus faecalis Isolated From Clinical and Environmental Sources: A Systematic Review and Meta‐Analysis
Vancomycin‐resistant enterococci (VRE) are an increasing public health concern. However, the contribution of environmental reservoirs to the global epidemiology of vancomycin resistance remains unclear. This meta‐analysis estimated the prevalence of Vancomycin‐resistant Enterococcus faecalis (VREfs) and vancomycin‐resistant Enterococcus faecium (VREfm) from clinical and environmental specimens worldwide. We conducted a systematic literature search in PubMed, Web of Science, Embase, and Scopus up to 26 April 2025. Statistical analysis was performed using the meta and metaphor packages in R, and heterogeneity was evaluated using I 2 . We assessed potential publication bias using Egger's test. A total of 349 eligible studies were included. The pooled prevalence of VREfm was 25%, and VREfs was 5%. The prevalence of both VREfs and VREfm increased significantly during the last two decades. The highest prevalence of VREfm and VREfs was found in rectal swabs (76%), hospital environmental samples (74%), environmental water (26%), and animal stool (40%). By integrating clinical and environmental data, the present study highlights the possible role of non‐clinical reservoirs in the persistence and dissemination of VRE. Our results support the One Health approach for VRE surveillance and emphasize the need for environmental surveillance in infection prevention and antimicrobial resistance control strategies.
- Open Access
- 10 October 2026
- Published by Elsevier in Infectious Medicine
- Vol. 5 (4)
A review on the beneficial and detrimental roles of gut microbiota-derived trimethylamine-N-oxide (TMAO)
- 10 October 2026
- Published by Elsevier in Infectious Medicine
- Vol. 5 (4)
Open AccessA review on the beneficial and detrimental roles of gut microbiota-derived trimethylamine-N-oxide (TMAO)
- Open Access
- 17 August 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (10)
Prevalence of methicillin-resistant Staphylococcus aureus in Iran: A systematic review and meta-analysis
- 17 August 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (10)
Open AccessPrevalence of methicillin-resistant Staphylococcus aureus in Iran: A systematic review and meta-analysis
- Open Access
- 2 July 2026
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 28, 1-45
Harnessing the Vaginal Microbiome: A New Frontier in the Prevention of Sexually Transmitted Infections
Background: The vaginal microbiome plays a vital role in maintaining reproductive and urogenital health in females. In healthy women, it is dominated by Lactobacillus species, including L. crispatus , L. gasseri , L. iners , and L. jensenii . These species provide strong protection against sexually transmitted infections (STIs) and other gynecological diseases. They produce lactic acid, which helps maintain a low vaginal pH, supporting epithelial integrity, modulating the immune system, and preventing colonization by bacterial pathogens. Dysbiosis, or an imbalance in microbial communities, is linked to higher susceptibility to infections like Chlamydia trachomatis , Neisseria gonorrhoeae , Trichomonas vaginalis , HIV, and HPV. The vaginal microbiota is dynamic and can change in response to hormonal shifts, sexual activity, antibiotic use, hygiene practices, and the duration of infection. Methods: This review provides a thorough overview of the composition, functions, and protective mechanisms of a healthy vaginal microbiome. Results: Recent research has shown that microbiome-based therapies, such as probiotics, prebiotics, synbiotics, and vaginal microbiota transplantation, may help restore vaginal microbial balance. Additionally, introducing engineered strains like L. jensenii that produce anti-HIV proteins offers promising new approaches to HIV treatment. Conclusions: This review also emphasizes therapeutic strategies aimed at stabilizing the vaginal microbiota to lower STI risk.
- 2 July 2026
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 28, 1-45
Open AccessHarnessing the Vaginal Microbiome: A New Frontier in the Prevention of Sexually Transmitted Infections
Background: The vaginal microbiome plays a vital role in maintaining reproductive and urogenital health in females. In healthy women, it is dominated by Lactobacillus species, including L. crispatus , L. gasseri , L. iners , and L. jensenii . These species provide strong protection against sexually transmitted infections (STIs) and other gynecological diseases. They produce lactic acid, which helps maintain a low vaginal pH, supporting epithelial integrity, modulating the immune system, and preventing colonization by bacterial pathogens. Dysbiosis, or an imbalance in microbial communities, is linked to higher susceptibility to infections like Chlamydia trachomatis , Neisseria gonorrhoeae , Trichomonas vaginalis , HIV, and HPV. The vaginal microbiota is dynamic and can change in response to hormonal shifts, sexual activity, antibiotic use, hygiene practices, and the duration of infection. Methods: This review provides a thorough overview of the composition, functions, and protective mechanisms of a healthy vaginal microbiome. Results: Recent research has shown that microbiome-based therapies, such as probiotics, prebiotics, synbiotics, and vaginal microbiota transplantation, may help restore vaginal microbial balance. Additionally, introducing engineered strains like L. jensenii that produce anti-HIV proteins offers promising new approaches to HIV treatment. Conclusions: This review also emphasizes therapeutic strategies aimed at stabilizing the vaginal microbiota to lower STI risk.
- Open Access
- 30 October 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (6) , e70087
Global Antimicrobial Resistance Trends in Group B Streptococcus Isolates From Pregnant Women: Systematic Review and Meta‐Analysis
Maternal colonization with Group B Streptococcus (GBS) is associated with a high risk of serious infections during pregnancy. Also, the emerging resistance of GBS isolates to commonly used antibiotics has become a serious concern. This study aimed to provide a systematic review and meta‐analysis of worldwide data on the prevalence of antimicrobial resistance of GBS in pregnant women to establish a better understanding of more effective antibiotic agents. A systematic literature search was performed in PubMed, Web of Science, and Scopus databases up to January 31, 2025. Statistical analysis was performed using the meta and metaphor packages in R, and sources of heterogeneity were evaluated using I 2 . The potential for publication bias was explored using Egger's and Begg's tests. A total of 169 eligible studies were included. The highest rate of resistance was associated with tetracycline (77.8%), while the lowest rates were found for vancomycin (0.59%), penicillin (0.7%), ampicillin (1%), and cefazolin (1.34%). The global resistance rates to penicillin, erythromycin, vancomycin, and clindamycin exhibited a gradual increasing trend in the 2021–2024 periods compared with other periods. The results highlighted the low levels of resistance to ampicillin and penicillin for pregnant women without an allergy history and cefazolin and vancomycin for those with an allergy history. However, given the increasing resistance trends and the high prevalence of resistance to clindamycin and erythromycin, these antibiotics should be recommended after antibiotic susceptibility testing.
- 30 October 2025
- Published by Wiley in Microbiologyopen
- Vol. 14 (6) , e70087
Open AccessGlobal Antimicrobial Resistance Trends in Group B Streptococcus Isolates From Pregnant Women: Systematic Review and Meta‐Analysis
Maternal colonization with Group B Streptococcus (GBS) is associated with a high risk of serious infections during pregnancy. Also, the emerging resistance of GBS isolates to commonly used antibiotics has become a serious concern. This study aimed to provide a systematic review and meta‐analysis of worldwide data on the prevalence of antimicrobial resistance of GBS in pregnant women to establish a better understanding of more effective antibiotic agents. A systematic literature search was performed in PubMed, Web of Science, and Scopus databases up to January 31, 2025. Statistical analysis was performed using the meta and metaphor packages in R, and sources of heterogeneity were evaluated using I 2 . The potential for publication bias was explored using Egger's and Begg's tests. A total of 169 eligible studies were included. The highest rate of resistance was associated with tetracycline (77.8%), while the lowest rates were found for vancomycin (0.59%), penicillin (0.7%), ampicillin (1%), and cefazolin (1.34%). The global resistance rates to penicillin, erythromycin, vancomycin, and clindamycin exhibited a gradual increasing trend in the 2021–2024 periods compared with other periods. The results highlighted the low levels of resistance to ampicillin and penicillin for pregnant women without an allergy history and cefazolin and vancomycin for those with an allergy history. However, given the increasing resistance trends and the high prevalence of resistance to clindamycin and erythromycin, these antibiotics should be recommended after antibiotic susceptibility testing.
- Open Access
- 1 January 2024
- Published by Wiley in International Journal of Microbiology
- Vol. 2024 (1) , 8224242
Antibiotic Resistance and Virulence Factors in Clinical Isolates of Stenotrophomonas maltophilia from Hospitalized Patients in Tehran, Iran
Stenotrophomonas maltophilia causes challenging infections in immunocompromised patients, exhibiting increasing resistance to multiple antimicrobials and possessing various virulence genes, including emerging resistance to trimethoprim‐sulfamethoxazole. A total of 80 clinical isolates of S. maltophilia were collected from multiple hospitals in Tehran, Iran. This study conducted an analysis of antibiotic susceptibility by disc diffusion method and E‐test assay, resistance and virulence gene frequencies were examined by PCR‐sequencing, and multilocus sequencing typing (MLST) was performed for strain typing. Across the tested isolates, we observed notably high resistance rates for imipenem 80 (100%), meropenem 78(97.5%), and ceftazidime 72 (90%), while trimethoprim‐sulfamethoxazole (SXT) showed a lower resistance rate of 2 (2.5%). Minocycline and levofloxacin demonstrated the highest susceptibility rates, with 70 (87.5%) and 80 (100%), respectively. The prevalence of antibiotic resistance genes blaL1, and blaL2 was 71 (88.75%) and 76 (95%), respectively. Additionally, the PCR analysis revealed that the frequency of virulence genes (fliC, virB, papD, pilU, hlyIII, stmPr1, and stmPr2) was 78 (97.5%), 77 (96.25%), 58 (72.5%), 77 (96.2%), 76 (95%), 31 (38.75%), and 80 (100%), respectively. Resistance to SXT isolate belong to the sequence type (ST15) and exhibits allelic profiles of (10, 29, 21, 21, 32, 32, and 10). The data obtained from our investigation have indicated that SXT remains an efficacious antibiotic and also highlighted the importance of effective management, identification of resistant isolates, and typing methods to address the global prevalence of antibiotic resistance in S. maltophilia.
- 1 January 2024
- Published by Wiley in International Journal of Microbiology
- Vol. 2024 (1) , 8224242
Open AccessAntibiotic Resistance and Virulence Factors in Clinical Isolates of Stenotrophomonas maltophilia from Hospitalized Patients in Tehran, Iran
Stenotrophomonas maltophilia causes challenging infections in immunocompromised patients, exhibiting increasing resistance to multiple antimicrobials and possessing various virulence genes, including emerging resistance to trimethoprim‐sulfamethoxazole. A total of 80 clinical isolates of S. maltophilia were collected from multiple hospitals in Tehran, Iran. This study conducted an analysis of antibiotic susceptibility by disc diffusion method and E‐test assay, resistance and virulence gene frequencies were examined by PCR‐sequencing, and multilocus sequencing typing (MLST) was performed for strain typing. Across the tested isolates, we observed notably high resistance rates for imipenem 80 (100%), meropenem 78(97.5%), and ceftazidime 72 (90%), while trimethoprim‐sulfamethoxazole (SXT) showed a lower resistance rate of 2 (2.5%). Minocycline and levofloxacin demonstrated the highest susceptibility rates, with 70 (87.5%) and 80 (100%), respectively. The prevalence of antibiotic resistance genes blaL1, and blaL2 was 71 (88.75%) and 76 (95%), respectively. Additionally, the PCR analysis revealed that the frequency of virulence genes (fliC, virB, papD, pilU, hlyIII, stmPr1, and stmPr2) was 78 (97.5%), 77 (96.25%), 58 (72.5%), 77 (96.2%), 76 (95%), 31 (38.75%), and 80 (100%), respectively. Resistance to SXT isolate belong to the sequence type (ST15) and exhibits allelic profiles of (10, 29, 21, 21, 32, 32, and 10). The data obtained from our investigation have indicated that SXT remains an efficacious antibiotic and also highlighted the importance of effective management, identification of resistant isolates, and typing methods to address the global prevalence of antibiotic resistance in S. maltophilia.
- Open Access
- 1 December 2023
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 17 (6) , 654-662
Molecular Analysis of the Ocular Microbiome Dominant Bacteria in Conjunctival Squamous Cell Carcinoma Patients
Background and Aim: Conjunctival squamous cell carcinoma (CSCC) is the final stage of ocular surface squamous neoplasia (OSSN). The microbiome plays a critical role in eye disease and health. Changes in the eye microbiome may be involved in the development of OSSN. Materials and Methods: The sampling for this case-control study involved rolling ...
- 1 December 2023
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 17 (6) , 654-662
Open AccessMolecular Analysis of the Ocular Microbiome Dominant Bacteria in Conjunctival Squamous Cell Carcinoma Patients
Background and Aim: Conjunctival squamous cell carcinoma (CSCC) is the final stage of ocular surface squamous neoplasia (OSSN). The microbiome plays a critical role in eye disease and health. Changes in the eye microbiome may be involved in the development of OSSN. Materials and Methods: The sampling for this case-control study involved rolling ...
- Open Access
- 23 November 2023
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14, 1302719
Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer
Background: Fusobacterium nucleatum has been recognized as an important key bacterium in the cause and spread of colorectal carcinogenesis. Nevertheless, the clinical relevance of F. nucleatum in colorectal cancer (CRC) and its effect on immune factors and the tumor microenvironment have not been fully elucidated.Materials and methods: The frequency of F. nucleatum was measured in 100 paired tumor and normal tissue specimens by TaqMan quantification Real-Time Polymerase Chain Reaction (qPCR). The mRNA expression levels of cytokines (IL-6, IL-10, IL-12β, IL-17, TNF-α, TLR-2, and TLR-4), and miRNAs (miR-21, miR-31) were examined. Eventually, any potential correlations between the molecular and clinicopathological features of the neoplastic samples and the abundance of F. nucleatum were analyzed.Results: The relative frequency of F. nucleatum was significantly increased in cancerous tissue compared to adjacent non-tumor tissues. Furthermore, the high level of F. nucleatum was significantly associated with histological grade III and IV CRC tissues (P = 0.027 and P = 0.022, respectively) and perineural invasion-positive patients (P = 0.037). In addition, the expression levels of IL-6, IL-17, TNF-α,IL-12β, TLR-2, and TLR-4 as well as miR-21 and miR-31 showed a significant increase in the cancer group. A notable correlation was also observed between the high status of F. nucleatum and the expression of IL-6, TNF-α and miR-21.Conclusion: Our results emphasize the importance of F. nucleatum and changes in the expression of genes involved in CRC. Studying the microbial profile and gene expression changes in CRC patients may be a promising approach to improve screening methods and provide therapeutic strategies.
- 23 November 2023
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14, 1302719
Open AccessExploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer
Background: Fusobacterium nucleatum has been recognized as an important key bacterium in the cause and spread of colorectal carcinogenesis. Nevertheless, the clinical relevance of F. nucleatum in colorectal cancer (CRC) and its effect on immune factors and the tumor microenvironment have not been fully elucidated.Materials and methods: The frequency of F. nucleatum was measured in 100 paired tumor and normal tissue specimens by TaqMan quantification Real-Time Polymerase Chain Reaction (qPCR). The mRNA expression levels of cytokines (IL-6, IL-10, IL-12β, IL-17, TNF-α, TLR-2, and TLR-4), and miRNAs (miR-21, miR-31) were examined. Eventually, any potential correlations between the molecular and clinicopathological features of the neoplastic samples and the abundance of F. nucleatum were analyzed.Results: The relative frequency of F. nucleatum was significantly increased in cancerous tissue compared to adjacent non-tumor tissues. Furthermore, the high level of F. nucleatum was significantly associated with histological grade III and IV CRC tissues (P = 0.027 and P = 0.022, respectively) and perineural invasion-positive patients (P = 0.037). In addition, the expression levels of IL-6, IL-17, TNF-α,IL-12β, TLR-2, and TLR-4 as well as miR-21 and miR-31 showed a significant increase in the cancer group. A notable correlation was also observed between the high status of F. nucleatum and the expression of IL-6, TNF-α and miR-21.Conclusion: Our results emphasize the importance of F. nucleatum and changes in the expression of genes involved in CRC. Studying the microbial profile and gene expression changes in CRC patients may be a promising approach to improve screening methods and provide therapeutic strategies.